Concepedia

Jonathan H. Ward

JH

Statistics

Publications

11

Citations

554

H-Index

11

Active since

2020

Affiliations

Brigham and Women's Hospital(Current)

Novartis (United States)

Clinical Research Institute

Harvard University

Duke Medical Center

Jonathan H. Ward is an author at Brigham and Women's Hospital specializing in heart failure, cardiology, and b-type natriuretic peptides.

ORCID

Publications per year

2020–2024

11

Publications

11

Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure

Robert J. Mentz, Jonathan H. Ward, Adrian F. Hernandez et al. · Journal of the American College of Cardiology · 2023 · 163 citations · Full text

, , +16

Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF

Muthiah Vaduganathan, Robert J. Mentz, Brian Claggett et al. · European Heart Journal · 2023 · 120 citations · Full text

, , +12

Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes

Muhammad Shahzeb Khan, G. Michael Felker, Ileana L. Piña et al. · JACC Heart Failure · 2020 · 49 citations · Full text

, , +14

Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction

Reza Mohebi, Yuxi Liu, Ileana L. Piña et al. · Journal of the American College of Cardiology · 2022 · 47 citations · Full text

, , +17

Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction

Sean Murphy, Margaret F. Prescott, Alan S. Maisel et al. · Circulation Heart Failure · 2021 · 38 citations

, , +16

1–5 of 11